Multiple Chronic Conditions in VLBW Infants: Epidemiology, NICU Care, and Outcome
Multiple Chronic Conditions in VLBW Infants: Epidemiology, NICU Care, and Outcome
批准号:
8015895
负责人:
WILLIAM GARDNER
金额:
$36.71万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2012-03-31
中文摘要
描述(由申请人提供):早产及其并发症是儿童出生后第一年死亡的主要原因,也是持续整个生命周期的发病原因。早产儿和极低出生体重儿(PVLBW,定义为胎龄d 32周,出生体重d 1500 g)在生命的第一年内死亡的可能性是正常婴儿的100倍,并且他们处于发育迟缓,功能障碍的高风险中,并且通常具有影响肺,肠道,大脑,眼睛和其他器官的多种复杂慢性疾病。特别是PVLBW儿童发生支气管肺发育不良(BPD)、坏死性小肠结肠炎(NEC)和脑室内出血(IVH)的风险较高。我们建议通过对儿科健康信息系统(PHIS)数据库中33家儿童医院2006- 2010年收治的15470名早产儿进行二次分析,对这些疾病的共同发生进行流行病学描述,观察这些慢性疾病对在NICU接受护理的PVLBW婴儿的影响。关注的结局包括NICU住院期间的死亡、NICU住院期间接受的治疗的累积负担以及从NICU出院后30天内再次住院。我们将:1)描述PVLBW婴儿在最初的NICU住院期间慢性疾病的发生率,单独和组合。2)描述慢性疾病(单独和组合)与首次入住NICU的三种结局之间的相关性:NICU住院期间的死亡、NICU住院期间接受的治疗的累积负担以及从NICU出院后的再次住院。3)我们将记录一个关键干预措施对结果的影响:使用吸入性一氧化氮预防和治疗BPD。在美国,早产和极低出生体重的比率都在上升。与美国其他人口相比,黑人中极低出生体重的比率超过2.5倍,因此是健康差异的一个重要向量。在所有分析中,我们将寻找基于种族或支付者身份的慢性疾病不同发病率、结局、治疗或疗效的证据。我们还将寻找医院或地区在慢性疾病的发病率、结局或治疗方面的差异。由于PVLBW婴儿通常患有多种慢性疾病,并且在服务不足的社区中比例过高,因此他们是比较有效性研究的优先人群。拟定的研究将具有重要意义,因为它将是首次在大样本中系统描述PVLBW婴儿中多种并发重度慢性疾病的发生率、结局和治疗,PVLBW婴儿是一个死亡率和发病率显著的人群。
公共卫生相关性:早产儿和极低出生体重儿(VLBW)死亡、发育迟缓、功能障碍的风险很高,通常患有多种复杂的慢性疾病,包括支气管肺发育不良(BPD)、坏死性小肠结肠炎(NEC)和脑室内出血(IVH)。我们建议通过对2006-2010年入住NICU的15470名早产儿进行二次分析,对这些疾病的共同发生进行流行病学描述。关注的结局包括死亡、接受治疗的累积负担和NICU出院后30天内再次住院。早产和极低出生体重在美国正在上升。极低出生体重的发生率是黑人的2.5倍以上,因此是健康差异的一个重要向量。由于PVLBW婴儿通常患有多种慢性疾病,并且在服务不足的社区中比例过高,因此他们是比较有效性研究的优先人群。
英文摘要
DESCRIPTION (provided by applicant): Prematurity and its complications are the leading causes of death among children in the first year of life and causes of morbidity lasting for the entire lifespan. Premature and very low birth weight infants (PVLBW, defined as gestational age d 32 weeks and birth weight d 1500g) are 100 times more likely than a normal infant to die in the first year of life, and they are at high risk for developmental delays, functional disabilities, and often have multiple complex chronic conditions affecting the lungs, gut, brain, eyes, and other organs. Specifically, PVLBW children are at high risk for bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), and intraventricular hemorrhages (IVH). We propose to conduct an epidemiologic description of the co-occurrence of these conditions, through a secondary analysis of 15470 premature children admitted to NICUs from 2006- 2010 at 33 children's hospitals in the Pediatric Health Information System (PHIS) database, looking at the effects of these chronic conditions on PVLBW infants receiving care in NICUs. The outcomes of interest include death during the NICU stay, cumulative burden of therapies received during the NICU stay, and re- hospitalization within 30 days following discharge from the NICU. We will: 1) Describe the incidence of the chronic conditions among PVLBW infants during the initial NICU admission, singly and in combination. 2) Describe the associations between the chronic conditions, singly and in combination, and three outcomes of the first NICU admission: death during the NICU stay, the cumulative burden of therapies received during the NICU stay, and re-hospitalization following discharge from the NICU. 3) We will document the consequences of one key intervention on the outcomes: the use of inhaled Nitric Oxide to prevent and treat BPD. The rates of both prematurity and VLBW are rising in the U.S. VLBW occurs at > 2.5 times the rate among blacks compared to the rest of the U.S. population and is therefore a significant vector of health disparities. In all analyses, we will look for evidence of disparate incidence, outcomes, treatment or efficacy of treatment of the chronic conditions based on race or payer status. We will also look for hospital- or region-specific variation in the incidence, outcomes, or treatment of the chronic conditions. Because PVLBW babies are often subject to multiple chronic disorders and are over-represented in an underserved community, they are a priority population for comparative effectiveness research. The proposed study will be significant because it will be the first to systematically describe, in a large sample, the incidence, outcomes, and treatment of multiple co- occurring severe chronic conditions in PVLBW infants, a population experiencing significant mortality and morbidity.
PUBLIC HEALTH RELEVANCE: PROJECT NARRATIVE Premature and very low birth weight (VLBW) infants are at high risk for death, developmental delays, functional disabilities, and often have multiple complex chronic conditions, including bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), and intraventricular hemorrhages (IVH). We propose to conduct an epidemiologic description of the co-occurrence of these conditions, through a secondary analysis of 15470 premature children admitted to NICUs from 2006-2010. The outcomes of interest include death, cumulative burden of therapies received, and re-hospitalization within 30 days following NICU discharge. Prematurity and VLBW are rising in the U.S. VLBW occurs at > 2.5 times the rate among blacks and is therefore a significant vector of health disparities. Because PVLBW babies are often subject to multiple chronic disorders and are over-represented in an underserved community, they are a priority population for comparative effectiveness research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pharmaceutical Safety Tracking (PhaST): Managing Medications for Patient Safety
-
批准号:7362688
-
项目类别:
-
资助金额:$26.47万
-
财政年份:2007
-
负责人:WILLIAM GARDNER
-
依托单位:
Pharmaceutical Safety Tracking (PhaST): Managing Medications for Patient Safety
-
批准号:7492248
-
项目类别:
-
资助金额:$49.84万
-
财政年份:2007
-
负责人:WILLIAM GARDNER
-
依托单位:
Pharmaceutical Safety Tracking (PhaST): Managing Medications for Patient Safety
-
批准号:7670281
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2007
-
负责人:WILLIAM GARDNER
-
依托单位:
Authorship and Conflicts of Interest in Clinical Trails
-
批准号:7058768
-
项目类别:
-
资助金额:$26.37万
-
财政年份:2004
-
负责人:WILLIAM GARDNER
-
依托单位:
Authorship and Conflicts of Interest in Clinical Trails
-
批准号:6829333
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2004
-
负责人:WILLIAM GARDNER
-
依托单位:
Authorship and Conflicts of Interest in Clinical Trails
-
批准号:6945793
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2004
-
负责人:WILLIAM GARDNER
-
依托单位:
Research Integrity in Pharmacologic Clinical Trials
-
批准号:6895322
-
项目类别:
-
资助金额:$3.79万
-
财政年份:2001
-
负责人:WILLIAM GARDNER
-
依托单位:
Research Integrity in Pharmacologic Clinical Trials
-
批准号:6529789
-
项目类别:
-
资助金额:$9.57万
-
财政年份:2001
-
负责人:WILLIAM GARDNER
-
依托单位:
Research Integrity in Pharmacologic Clinical Trials
-
批准号:6407010
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2001
-
负责人:WILLIAM GARDNER
-
依托单位:
DEVELOPMENT OF DECISION MAKING
-
批准号:3474578
-
项目类别:
-
资助金额:$6.26万
-
财政年份:1988
-
负责人:WILLIAM GARDNER
-
依托单位:
DEVELOPMENT OF DECISION MAKING
-
批准号:3474579
-
项目类别:
-
资助金额:$2.43万
-
财政年份:1988
-
负责人:WILLIAM GARDNER
-
依托单位:
DEVELOPMENT OF DECISION MAKING
-
批准号:3474577
-
项目类别:
-
资助金额:$6.75万
-
财政年份:1988
-
负责人:WILLIAM GARDNER
-
依托单位:
THE DEVELOPMENT OF DECISION MAKING
-
批准号:3474580
-
项目类别:
-
资助金额:$4.42万
-
财政年份:1988
-
负责人:WILLIAM GARDNER
-
依托单位:
THE DEVELOPMENT OF DECISION MAKING
-
批准号:3428316
-
项目类别:
-
资助金额:$2.16万
-
财政年份:1985
-
负责人:WILLIAM GARDNER
-
依托单位:
海外基金